Cargando…

Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana

BACKGROUND: In 2008, artemether - lumefantrine (AL) and dihydroartemisinin - piperaquine (DHAP) were added to artesunate - amodiaquine (AS-AQ) as first-line drugs for uncomplicated malaria in Ghana. The introduction of new drugs calls for continuous monitoring of these drugs to provide timely inform...

Descripción completa

Detalles Bibliográficos
Autores principales: Abuaku, Benjamin, Duah, Nancy, Quaye, Lydia, Quashie, Neils, Koram, Kwadwo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519607/
https://www.ncbi.nlm.nih.gov/pubmed/23173737
http://dx.doi.org/10.1186/1475-2875-11-388
_version_ 1782252698277511168
author Abuaku, Benjamin
Duah, Nancy
Quaye, Lydia
Quashie, Neils
Koram, Kwadwo
author_facet Abuaku, Benjamin
Duah, Nancy
Quaye, Lydia
Quashie, Neils
Koram, Kwadwo
author_sort Abuaku, Benjamin
collection PubMed
description BACKGROUND: In 2008, artemether - lumefantrine (AL) and dihydroartemisinin - piperaquine (DHAP) were added to artesunate - amodiaquine (AS-AQ) as first-line drugs for uncomplicated malaria in Ghana. The introduction of new drugs calls for continuous monitoring of these drugs to provide timely information on trends of their efficacy and safety to enhance timely evidence-based decision making by the National Malaria Control Programme. In this regard, the therapeutic efficacy of AL was monitored from September 2010 to April 2011 in four sentinel sites representing the three main ecological zones of the country. METHODS: The study was a one-arm prospective evaluation of clinical and parasitological responses to directly observed treatment for uncomplicated malaria among children aged 6 months to 59 months using the 2009 WHO protocol for surveillance of anti-malarial drug efficacy. Children recruited into the study received weight-based 20/120 mg AL at 0, 8, 24, 36, 48, and 60 hrs. Parasitaemia levels were assessed on days 2, 3, 7, 14, 21, 28, and at any time a study child was brought to the clinic with fever. RESULTS: A total of 175 children were enrolled into the study: 56 in the savanna zone, 78 in the forest zone and 41 in the coastal zone. Per-protocol analysis showed that the overall PCR-corrected cure rates on day 14 and day 28 were 96.5% (95% CI: 92.1, 98.6) and 95.4% (95% CI: 90.3, 98.0), respectively, with statistically significant differences between the ecological zones. The 90.4% day-28 cure rate observed in the savannah zone (95% CI: 78.2, 96.4) was significantly the lowest compared with 100% (95% CI: 93.2, 99.9) in the forest zone and 93.8% (95% CI: 77.8, 98.9) in the coastal zone (P = 0.017). Fever and parasite clearance were slower among children enrolled in the savannah zone. Gametocytaemia after day-3 post-treatment was rare in all the zones. CONCLUSIONS: The study has shown that AL remains efficacious in Ghana with significant ecologic zonal differences. The savannah zone may be a potential zone for any emergence of resistant alleles as a result of the slower parasite clearance observed in the zone.
format Online
Article
Text
id pubmed-3519607
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35196072012-12-12 Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana Abuaku, Benjamin Duah, Nancy Quaye, Lydia Quashie, Neils Koram, Kwadwo Malar J Research BACKGROUND: In 2008, artemether - lumefantrine (AL) and dihydroartemisinin - piperaquine (DHAP) were added to artesunate - amodiaquine (AS-AQ) as first-line drugs for uncomplicated malaria in Ghana. The introduction of new drugs calls for continuous monitoring of these drugs to provide timely information on trends of their efficacy and safety to enhance timely evidence-based decision making by the National Malaria Control Programme. In this regard, the therapeutic efficacy of AL was monitored from September 2010 to April 2011 in four sentinel sites representing the three main ecological zones of the country. METHODS: The study was a one-arm prospective evaluation of clinical and parasitological responses to directly observed treatment for uncomplicated malaria among children aged 6 months to 59 months using the 2009 WHO protocol for surveillance of anti-malarial drug efficacy. Children recruited into the study received weight-based 20/120 mg AL at 0, 8, 24, 36, 48, and 60 hrs. Parasitaemia levels were assessed on days 2, 3, 7, 14, 21, 28, and at any time a study child was brought to the clinic with fever. RESULTS: A total of 175 children were enrolled into the study: 56 in the savanna zone, 78 in the forest zone and 41 in the coastal zone. Per-protocol analysis showed that the overall PCR-corrected cure rates on day 14 and day 28 were 96.5% (95% CI: 92.1, 98.6) and 95.4% (95% CI: 90.3, 98.0), respectively, with statistically significant differences between the ecological zones. The 90.4% day-28 cure rate observed in the savannah zone (95% CI: 78.2, 96.4) was significantly the lowest compared with 100% (95% CI: 93.2, 99.9) in the forest zone and 93.8% (95% CI: 77.8, 98.9) in the coastal zone (P = 0.017). Fever and parasite clearance were slower among children enrolled in the savannah zone. Gametocytaemia after day-3 post-treatment was rare in all the zones. CONCLUSIONS: The study has shown that AL remains efficacious in Ghana with significant ecologic zonal differences. The savannah zone may be a potential zone for any emergence of resistant alleles as a result of the slower parasite clearance observed in the zone. BioMed Central 2012-11-22 /pmc/articles/PMC3519607/ /pubmed/23173737 http://dx.doi.org/10.1186/1475-2875-11-388 Text en Copyright ©2012 Abuaku et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Abuaku, Benjamin
Duah, Nancy
Quaye, Lydia
Quashie, Neils
Koram, Kwadwo
Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana
title Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana
title_full Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana
title_fullStr Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana
title_full_unstemmed Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana
title_short Therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in Ghana
title_sort therapeutic efficacy of artemether-lumefantrine combination in the treatment of uncomplicated malaria among children under five years of age in three ecological zones in ghana
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519607/
https://www.ncbi.nlm.nih.gov/pubmed/23173737
http://dx.doi.org/10.1186/1475-2875-11-388
work_keys_str_mv AT abuakubenjamin therapeuticefficacyofartemetherlumefantrinecombinationinthetreatmentofuncomplicatedmalariaamongchildrenunderfiveyearsofageinthreeecologicalzonesinghana
AT duahnancy therapeuticefficacyofartemetherlumefantrinecombinationinthetreatmentofuncomplicatedmalariaamongchildrenunderfiveyearsofageinthreeecologicalzonesinghana
AT quayelydia therapeuticefficacyofartemetherlumefantrinecombinationinthetreatmentofuncomplicatedmalariaamongchildrenunderfiveyearsofageinthreeecologicalzonesinghana
AT quashieneils therapeuticefficacyofartemetherlumefantrinecombinationinthetreatmentofuncomplicatedmalariaamongchildrenunderfiveyearsofageinthreeecologicalzonesinghana
AT koramkwadwo therapeuticefficacyofartemetherlumefantrinecombinationinthetreatmentofuncomplicatedmalariaamongchildrenunderfiveyearsofageinthreeecologicalzonesinghana